Clinical meaning
Biofilms are organized communities of microorganisms embedded in a self-produced extracellular polymeric substance (EPS) matrix that adheres to surfaces, particularly medical devices. Biofilm formation proceeds through attachment, microcolony formation, maturation, and dispersal phases. Within biofilms, bacteria are 100-1,000 times more resistant to antibiotics compared to planktonic (free-floating) bacteria due to the protective EPS matrix, reduced metabolic activity, and efflux pump upregulation. Common device-associated infections include central line-associated bloodstream infections (CLABSIs), catheter-associated urinary tract infections (CAUTIs), and ventilator-associated pneumonia (VAP). Prevention bundles targeting device insertion, maintenance, and timely removal are the most effective strategies. The CDC estimates that 50-70% of HAIs are related to indwelling medical devices, making device management a critical nursing responsibility.
Exam relevance
Risk factors: - Prolonged indwelling device duration (central lines, urinary catheters, ET tubes) - Break in aseptic technique during device insertion or maintenance - Immunocompromised status reducing ability to fight device-associated biofilm - Contaminated hub or connection point creating entry for organisms - Failure to implement evidence-based prevention bundles